Innovation and collaboration for microbiome therapeutics at Microbiome Connect

Microbiome Connect is an event where a community of 300 scientists and entrepreneurs converge, sharing a common passion for the microbiome. The event's purpose is to unite individuals committed to delivering inventive products to patients. Experts from various perspectives collaborate to create a platform enabling the unlocking of the microbiome's complete therapeutic potential.

Amanda Burkardt, Chief Executive Officer at Phiogen is one of 65 trailblazing speakers at the upcoming Microbiome Connect: USA event in Boston, November 14-16. In this video, Burkardt discusses Phiogen's mission, the main benefits of phage therapy, emerging modalities in the microbiome world, and shares a sneak peek into what will be covered in their session at Microbiome Connect: USA.

For more information about this event and to register your space, click here.